CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vascular Solutions, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vascular Solutions, Inc.
6464 Sycamore Court North
Phone: (763) 656-4300p:763 656-4300 Minneapolis, MN  55369-6032  United States Fax: (877) 656-4251f:877 656-4251

This company was Merged or Acquired on 2/17/2017.
This company ceased filing statements with the SEC on 2/28/2017.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company's product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company's product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201612/31/2015YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board John L.Erb 67 5/1/2011 10/16/2002
Chief Executive Officer and Director Howard C.Root 55 2/1/1997 2/1/1997
Chief Financial Officer, Senior Vice President - Finance, Corporate Secretary JamesHennen 43 1/1/2012 1/1/2004
9 additional Officers and Directors records available in full report.

Business Names
Business Name
EXPRO Elite
MICRO Elite
Oracle
5 additional Business Names available in full report.

General Information
Number of Employees: 568 (As of 12/31/2015)
Outstanding Shares: 17,568,375 (As of 1/13/2017)
Shareholders: 483
Stock Exchange: NASD
Federal Tax Id: 411859679
Fax Number: (877) 656-4251
Email Address: investorrelations@vascularsolutions.com.


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023